Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOV-002 in Low and Intermediate-1 Risk Myelodysplastic Syndrome
NCT00960726Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 2 trial of glutathione disulfide in myelodysplastic syndrome (MDS), sponsored by University of Texas MD Anderson Cancer Center. Status: withdrawn.
02
Drugs
glutathione disulfide
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00960726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00960726.